Tarsus Pharmaceuticals (TARS) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
TARS is expected to report earnings to rise 55.64% to -94 cents per share on March 17
Q4'24
Est.
$-0.95
Q3'24
Beat
by $0.33
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.17
Q4'23
Beat
by $0.07
The last earnings report on November 13 showed earnings per share of -61 cents, beating the estimate of -93 cents. With 589.21K shares outstanding, the current market capitalization sits at 1.84B.